Adela López de Cerain Selected Research

quindoxin

10/2018	Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
6/2007	A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adela López de Cerain Research Topics

Disease

4	Hypoxia (Hypoxemia) 06/2007 - 01/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Parkinson Disease (Parkinson's Disease) 10/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Infections 10/2018
1	Inflammation (Inflammations) 02/2015
1	Necrosis 02/2015
1	Myotoxicity 11/2009

Drug/Important Bio-Agent (IBA)

3	7- chloro- 3- (((N,N- dimethylamino)propyl)amino)- 2- quinoxalinecarbonitrile- 1,4- di- N- oxideIBA 06/2007 - 01/2005
2	quindoxinIBA 10/2018 - 06/2007
1	MycotoxinsIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Primaquine FDA Link 10/2018
1	Alanine Transaminase (SGPT)IBA 02/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2015
1	stachydrineIBA 11/2009
1	Vitamin E FDA LinkGeneric 06/2007
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2007
1	pyrimidineIBA 06/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2007
1	OxidesIBA 06/2007
1	purineIBA 06/2007
1	LigandsIBA 05/2005
1	DNA (Deoxyribonucleic Acid)IBA 05/2005
1	Cytotoxins (Cytolysins)IBA 05/2005
1	QuinoxalinesIBA 05/2005